Viewing Study NCT05704933


Ignite Creation Date: 2025-12-25 @ 3:02 AM
Ignite Modification Date: 2026-03-05 @ 6:03 PM
Study NCT ID: NCT05704933
Status: COMPLETED
Last Update Posted: 2025-10-20
First Post: 2023-01-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Melanoma View
None Metastasis to Brain View
Keywords: